Novel NLRP3 inflammasome inhibitors INF150 and INF195 attenuate isoproterenol-induced hypertrophy in H9c2 rat cardiac myoblast

IF 3.5 3区医学 Q2 PHARMACOLOGY & PHARMACY

Vascular pharmacology Pub Date : 2024-06-01 DOI:10.1016/j.vph.2024.107321

Magalì Giordano , Chiara Rubeo , Tommaso Angelone , Giovanna Gambarotta , Stefano Comità , Francesco Fedele , Massimo Bertinaria , Pasquale Pagliaro , Claudia Penna

引用次数: 0

查看原文本刊更多论文

新型 NLRP3 炎症小体抑制剂 INF150 和 INF195 可减轻异丙肾上腺素诱导的 H9c2 大鼠心肌细胞肥大

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Vascular pharmacology 医学-药学

CiteScore

6.60

自引率

2.50%

发文量

153

审稿时长

31 days

期刊介绍： Vascular Pharmacology publishes papers, which contains results of all aspects of biology and pharmacology of the vascular system. Papers are encouraged in basic, translational and clinical aspects of Vascular Biology and Pharmacology, utilizing approaches ranging from molecular biology to integrative physiology. All papers are in English. The Journal publishes review articles which include vascular aspects of thrombosis, inflammation, cell signalling, atherosclerosis, and lipid metabolism.

文献相关原料

公司名称	产品信息	采购帮参考价格